Watershed Asset Management, L.L.C. Abb Vie Inc. Transaction History

Watershed Asset Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$144.61 - $166.54 $6,073 - $6,994	-42 Reduced 2.42%	1,695 $270,000
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $16,873 - $20,236	122 Added 7.55%	1,737 $280,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $24,023 - $27,553	-179 Reduced 9.98%	1,615 $217,000
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $14,174 - $18,020	103 Added 6.09%	1,794 $275,000
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $41,177 - $51,090	-312 Reduced 15.58%	1,691 $274,000
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $215,182 - $272,267	2,003 New	2,003 $271,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Watershed Asset Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Watershed Asset Management, L.L.C. with notifications on news.